Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo agent, E-6011, represents a novel treatment targeting PD-1. Initial medical results from the two studies, KANAb 001 and E-6011, suggest significant response in https://dirstop.com/story28297254/text